Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDUA | P35475 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20888665 | 0.77 | IDUA (0.33) | IDUA | |
| SCHEMBL22096149 | 0.77 | IDUA (0.33) | IDUA | |
| SCHEMBL20888684 | 0.76 | PYGB (0.44) | — | |
| SCHEMBL14432962 | 0.76 | PYGB (0.44) | — | |
| SCHEMBL20888681 | 0.76 | PYGB (0.44) | — | |
| SCHEMBL18820182 | 0.76 | PYGB (0.44) | — | |
| SCHEMBL18805897 | 0.76 | PYGB (0.44) | — | |
| SCHEMBL18819607 | 0.74 | PYGB (0.39) | IDUA | |
| SCHEMBL18819604 | 0.74 | PYGB (0.39) | IDUA | |
| SCHEMBL17256226 | 0.70 | IDUA (0.38) | IDUA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8871744-B2 | Compounds and methods for selectively targeting tumor-associated mucins | B & G Partyers, LLC (US) | 2014-10-28 | — | — | US | disclosed |
| US-8778892-B2 | Compounds and methods for treatment of solid tumors | B & G PARTNERS, LLC (US) | 2014-07-15 | — | — | US | disclosed |
| US-20120295284-A1 | Fluorecent Saccharide Conjugates | B&G PARTNERS, LLC | 2012-11-22 | — | — | US | disclosed |
| US-20120022016-A1 | Compounds and methods for selectively targeting tumor-associated mucins | B&G PARTNERS, LLC | 2012-01-26 | — | — | US | disclosed |
| EP-2409708-A1 | Compounds and methods for selectively targeting tumor-associated mucins | B & G Partners, LLC (US) | 2012-01-25 | — | — | EP | disclosed |
| US-20100240878-A1 | Fluorescent saccharide conjugates | B&G PARTNERS, LLC | 2010-09-23 | — | — | US | disclosed |
| US-20090239820-A1 | Compounds and methods for treatment of solid tumors | BARBEAU DONALD L | 2009-09-24 | — | — | US | disclosed |
| US-5952313-A | COMPOSITION FOR ANTAGONIZING GRAM NEGATIVE BACTERIAL ENDOTOXIC ACTIVITY, COMPRISING A PHARMACEUTICALLY ACCEPTABLE CARRIER AND AN ANTAGONIZING AMOUNT OF A LIPOPOLYSACCHARIDE FROM A RHIZOBIUM ETLI; TREATMENT OF SEPTIC SHOCK OR TOXIC SHOCK | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1999-09-14 | — | — | US | disclosed |
| EP-0824538-A1 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | GLYCOMED INCORPORATED (US) | 1998-02-25 | — | — | EP | disclosed |
| US-5648343-A | ADMINISTERING A LIPID | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) | 1997-07-15 | — | — | US | disclosed |
| WO-1996035700-A9 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | — | 1997-02-13 | — | — | WO | disclosed |
| EP-0748327-A1 | STRUCTURE OF A NOVEL LIPID A AND METHODS UTILIZING SAME | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1996-12-18 | — | — | EP | disclosed |
| WO-1996035700-A1 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | GLYCOMED INCORPORATED (US) | 1996-11-14 | — | — | WO | disclosed |
| WO-1995023156-A1 | STRUCTURE OF A NOVEL LIPID A AND METHODS UTILIZING SAME | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1995-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240878-A1 | Fluorescent saccharide conjugates | CD44, FUT6, SIGLEC7 | IDUA 547/4885 |
| US-20120022016-A1 | Compounds and methods for selectively targeting tumor-associated mucins | MUC1, NEU4, ALK | IDUA 108/4885 |
| US-20090239820-A1 | Compounds and methods for treatment of solid tumors | VHL, HCAR1, HCAR2 | IDUA 158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.